Sisu Global

Sisu Global Health is a women-founded medical technology company established in 2014 in the USA. The company focuses on addressing healthcare disparities in emerging markets by developing innovative medical devices tailored for low-resource environments. Their mission is to create a standardized pathway from design to sale that improves health outcomes while ensuring profitability to sustain their initiatives. One of their key products is Hemafuse, a handheld autotransfusion device that allows clinicians to recycle a patient’s own blood during internal bleeding, reducing reliance on donor blood. Hemafuse has been extensively tested for safety and usability in low-resource settings and has received recognition from organizations like USAID and the Gates Foundation. Sisu Global Health also develops other patented technologies designed with input from various stakeholders, ensuring that their devices are affordable and easy to repair. The company has expanded its reach to at least five countries and has contributed to humanitarian efforts, including providing Hemafuse devices for surgeries during the Ukraine crisis. Sisu Global Health partners with distributors in Africa and other emerging markets to commercialize their products and has received multiple innovation awards for their work.

• Employees 8
• Founded 2014
• Total Funding $2300000